/NOUV

NOUV Stock - Nouveau Life Pharmaceuticals, Inc.

Q: What is the analyst price target for NOUV?

Analyst price target information is not currently available for NOUV.

Q: What is NOUV's market cap?

Market capitalization information is not currently available for NOUV.

Financial Services|Shell Companies|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NOUV

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2004

FY2005

FY2006

FY2007

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.49

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2007	FY2006	FY2005	FY2004
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-17,212	$357,248	$267,316	$318,006	$229,360
Net Income	$-17,212	$-357,248	$-256,816	$-401,431	$-312,249
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$0.00	$-0.01	$-0.01	$-0.02	$-0.01

Company Overview

Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. It provides natural alternatives and prescription drugs. The company was formerly known as Hybrid Fuels, Inc. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 2012. Nouveau Life Pharmaceuticals, Inc. was incorporated in 1998 and is based in Ft. Lauderdale, Florida. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc.

Frequently Asked Questions about NOUV

What is NOUV's current stock price?

Nouveau Life Pharmaceuticals, Inc. (NOUV) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for NOUV?

No analyst price targets are currently available for this stock.

What sector is Nouveau Life Pharmaceuticals, Inc. in?

Nouveau Life Pharmaceuticals, Inc. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the OTC exchange.

What is NOUV's market cap?

Nouveau Life Pharmaceuticals, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does NOUV pay dividends?

No, Nouveau Life Pharmaceuticals, Inc. does not currently pay a dividend to shareholders.